BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20444664)

  • 1. Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: fluorescence in situ hybridization and cytogenetic studies.
    Demirhan O; Taştemir D; Hastürk S; Kuleci S; Hanta I
    Cancer Epidemiol; 2010 Aug; 34(4):472-7. PubMed ID: 20444664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome imbalances and alterations of AURKA and MYCN genes in children with neuroblastoma.
    Inandiklioğlu N; Yilmaz S; Demirhan O; Erdoğan S; Tanyeli A
    Asian Pac J Cancer Prev; 2012; 13(11):5391-7. PubMed ID: 23317189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
    Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases.
    Nordgren A; Heyman M; Sahlén S; Schoumans J; Söderhäll S; Nordenskjöld M; Blennow E
    Eur J Haematol; 2002 Jan; 68(1):31-41. PubMed ID: 11952819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.
    Luk C; Tsao MS; Bayani J; Shepherd F; Squire JA
    Cancer Genet Cytogenet; 2001 Mar; 125(2):87-99. PubMed ID: 11369051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer.
    Panani AD; Maliaga K; Babanaraki A; Bellenis I
    Anticancer Res; 2009 Nov; 29(11):4483-7. PubMed ID: 20032395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
    Stankovic T; Milinkovic V; Bankovic J; Dinic J; Tanic N; Dramicanin T; Tanic N
    Biomed Pharmacother; 2014 Jun; 68(5):521-6. PubMed ID: 24767865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens.
    Fahmy M; Skacel M; Gramlich TL; Brainard JA; Rice TW; Goldblum JR; Connor JT; Casey G; Legator MS; Tubbs RR; Falk GW
    Mod Pathol; 2004 May; 17(5):588-96. PubMed ID: 15017433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome imbalances and alterations in the p53 gene in uterine myomas from the same family members: familial leiomyomatosis in Turkey.
    Hakverdi S; Demirhan O; Tunc E; Inandiklioglu N; Uslu IN; Gungoren A; Erdem D; Hakverdi AU
    Asian Pac J Cancer Prev; 2013; 14(2):651-8. PubMed ID: 23621213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
    Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
    Stadler WM; Steinberg G; Yang X; Hagos F; Turner C; Olopade OI
    Clin Cancer Res; 2001 Jun; 7(6):1676-82. PubMed ID: 11410506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancer.
    Abat D; Demirhan O; Inandiklioglu N; Tunc E; Erdogan S; Tastemir D; Uslu IN; Tansug Z
    Oncol Lett; 2014 Jul; 8(1):25-32. PubMed ID: 24959214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locus/chromosome aberrations in intraductal papillary mucinous neoplasms analyzed by fluorescence in situ hybridization.
    Miyabe K; Hori Y; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Kato A; Ohara H; Joh T; Inagaki H
    Am J Surg Pathol; 2015 Apr; 39(4):512-20. PubMed ID: 25517961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between fluorescence in situ hybridization and classical cytogenetics in human tumors.
    Virmani AK; Tonk VS; Gazdar AF
    Anticancer Res; 1998; 18(3A):1351-6. PubMed ID: 9673339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent chromosome alterations in non-small cell lung cancer.
    Matturri L; Lavezzi AM
    Eur J Histochem; 1994; 38(1):53-8. PubMed ID: 7517731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
    Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.